Kelly Lawrence W & Associates Inc. CA Sells 612 Shares of CVS Health Corporation (CVS)

Kelly Lawrence W & Associates Inc. CA lowered its holdings in shares of CVS Health Corporation (NYSE:CVS) by 22.7% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 2,082 shares of the pharmacy operator’s stock after selling 612 shares during the period. Kelly Lawrence W & Associates Inc. CA’s holdings in CVS Health Corporation were worth $167,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in CVS. Keel Point LLC grew its holdings in CVS Health Corporation by 0.7% in the 1st quarter. Keel Point LLC now owns 3,296 shares of the pharmacy operator’s stock worth $259,000 after acquiring an additional 22 shares during the last quarter. First City Capital Management Inc. grew its holdings in CVS Health Corporation by 0.3% in the 1st quarter. First City Capital Management Inc. now owns 12,771 shares of the pharmacy operator’s stock worth $1,003,000 after acquiring an additional 40 shares during the last quarter. Elefante Mark B grew its holdings in CVS Health Corporation by 0.7% in the 2nd quarter. Elefante Mark B now owns 6,400 shares of the pharmacy operator’s stock worth $515,000 after acquiring an additional 45 shares during the last quarter. Norway Savings Bank grew its holdings in CVS Health Corporation by 0.3% in the 2nd quarter. Norway Savings Bank now owns 17,014 shares of the pharmacy operator’s stock worth $1,368,000 after acquiring an additional 50 shares during the last quarter. Finally, Sheets Smith Wealth Management grew its holdings in CVS Health Corporation by 0.6% in the 2nd quarter. Sheets Smith Wealth Management now owns 9,171 shares of the pharmacy operator’s stock worth $738,000 after acquiring an additional 55 shares during the last quarter. 81.51% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: “Kelly Lawrence W & Associates Inc. CA Sells 612 Shares of CVS Health Corporation (CVS)” was posted by Community Financial News and is owned by of Community Financial News. If you are viewing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.com-unik.info/2017/10/13/kelly-lawrence-w-associates-inc-ca-sells-612-shares-of-cvs-health-corporation-cvs.html.

CVS Health Corporation (NYSE:CVS) last released its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.31 by $0.02. The business had revenue of $45.69 billion during the quarter, compared to analyst estimates of $45.36 billion. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The company’s quarterly revenue was up 4.5% on a year-over-year basis. During the same period in the prior year, the firm posted $1.32 earnings per share.

The company also recently declared a quarterly dividend, which will be paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.71%. The ex-dividend date of this dividend is Monday, October 23rd. CVS Health Corporation’s payout ratio is 39.92%.

A number of equities research analysts have issued reports on CVS shares. Royal Bank Of Canada started coverage on shares of CVS Health Corporation in a report on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 price target on the stock. Leerink Swann set a $90.00 price target on shares of CVS Health Corporation and gave the stock a “buy” rating in a report on Tuesday, June 27th. Robert W. Baird reissued an “outperform” rating and issued a $90.00 price target on shares of CVS Health Corporation in a report on Monday, August 14th. Loop Capital started coverage on shares of CVS Health Corporation in a report on Thursday, August 24th. They issued a “hold” rating and a $83.00 price target on the stock. Finally, Jefferies Group LLC raised their price target on shares of CVS Health Corporation from $82.00 to $86.00 and gave the stock a “hold” rating in a report on Friday, September 15th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and sixteen have assigned a buy rating to the company. CVS Health Corporation presently has a consensus rating of “Buy” and an average price target of $90.23.

In other CVS Health Corporation news, Director Richard J. Swift sold 2,500 shares of the stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $79.62, for a total transaction of $199,050.00. Following the completion of the sale, the director now directly owns 3,258 shares of the company’s stock, valued at $259,401.96. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Thomas M. Moriarty sold 90,267 shares of the stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $79.61, for a total transaction of $7,186,155.87. Following the sale, the executive vice president now directly owns 70,102 shares of the company’s stock, valued at $5,580,820.22. The disclosure for this sale can be found here. Over the last three months, insiders have sold 716,625 shares of company stock valued at $58,318,431. Insiders own 0.61% of the company’s stock.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

What are top analysts saying about CVS Health Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CVS Health Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit